INOVIO PHARMACEUTICALS, INC. Interest and Other Income
INOVIO PHARMACEUTICALS, INC. (INO) reported Interest and Other Income of -$169.30 thousand for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2019-03-12
- INOVIO PHARMACEUTICALS, INC. interest and other income for the quarter ending 2018-12-31 was -$169.30K, a 133.24% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. interest and other income for the quarter ending 2018-09-30 was $380.99K, a 17.77% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. interest and other income for the quarter ending 2018-06-30 was $396.68K, a 32.22% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. interest and other income for the quarter ending 2018-03-31 was $312.52K, a 8.17% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. interest and other income for fiscal 2018 was $920.89K, a 42.91% decline from fiscal 2017.
- INOVIO PHARMACEUTICALS, INC. interest and other income for fiscal 2017 was $1.61M, a 28.29% increase from fiscal 2016.
- INOVIO PHARMACEUTICALS, INC. interest and other income for fiscal 2016 was $1.26M, a 312.12% increase from fiscal 2015.
- INOVIO PHARMACEUTICALS, INC. interest and other income for fiscal 2015 was $305.07K, a 7.96% decline from fiscal 2014.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$169.30K 10-K · filed 2019-03-12 | $211.69K derived: sum of 2 quarters · filed 2019-03-12 | $608.37K derived: sum of 3 quarters · filed 2019-03-12 | $920.89K 10-K · filed 2019-03-12 |
| 2018-09-30 | $380.99K 10-K · filed 2019-03-12 | $777.67K derived: sum of 2 quarters · filed 2019-03-12 | $1.09M 10-Q · filed 2018-11-08 | $1.60M derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-06-30 | $396.68K 10-K · filed 2019-03-12 | $709.20K 10-Q · filed 2018-08-07 | $1.22M derived: sum of 3 quarters · filed 2019-03-12 | $1.68M derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-03-31 | $312.52K 10-K · filed 2019-03-12 | $821.79K derived: sum of 2 quarters · filed 2019-03-12 | $1.29M derived: sum of 3 quarters · filed 2019-03-12 | $1.59M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-12-31 | $509.27K 10-K · filed 2019-03-12 | $972.61K derived: sum of 2 quarters · filed 2019-03-12 | $1.27M derived: sum of 3 quarters · filed 2019-03-12 | $1.61M 10-K · filed 2019-03-12 |
| 2017-09-30 | $463.35K 10-K · filed 2019-03-12 | $763.37K derived: sum of 2 quarters · filed 2019-03-12 | $1.10M 10-Q · filed 2018-11-08 | $1.30M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $300.02K 10-K · filed 2019-03-12 | $640.36K 10-Q · filed 2018-08-07 | $831.82K derived: sum of 3 quarters · filed 2019-03-12 | $1.22M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $340.34K 10-K · filed 2019-03-12 | $531.80K derived: sum of 2 quarters · filed 2019-03-12 | $923.40K derived: sum of 3 quarters · filed 2019-03-12 | $1.26M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $191.46K 10-K · filed 2018-03-14 | $583.06K derived: sum of 2 quarters · filed 2018-03-14 | $924.19K derived: sum of 3 quarters · filed 2018-03-14 | $1.26M 10-K · filed 2019-03-12 |
| 2016-09-30 | $391.60K 10-K · filed 2018-03-14 | $732.73K derived: sum of 2 quarters · filed 2018-03-14 | $1.07M 10-Q · filed 2017-11-08 | $871.28K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $341.13K 10-K · filed 2018-03-14 | $674.20K 10-Q · filed 2017-08-08 | $479.68K derived: sum of 3 quarters · filed 2018-03-14 | $694.66K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $333.07K 10-K · filed 2018-03-14 | $138.55K derived: sum of 2 quarters · filed 2018-03-14 | $353.53K derived: sum of 3 quarters · filed 2018-03-14 | $499.87K derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | -$194.52K 10-K · filed 2017-03-15 | $20.46K derived: sum of 2 quarters · filed 2017-03-15 | $166.79K derived: sum of 3 quarters · filed 2017-03-15 | $305.07K 10-K · filed 2018-03-14 |
| 2015-09-30 | $214.98K 10-K · filed 2017-03-15 | $361.31K derived: sum of 2 quarters · filed 2017-03-15 | $499.59K 10-Q · filed 2016-11-09 | $612.80K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $146.33K 10-K · filed 2017-03-15 | $284.61K 10-Q · filed 2016-08-08 | $397.82K derived: sum of 3 quarters · filed 2017-03-15 | $494.99K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $138.28K 10-K · filed 2017-03-15 | $251.49K derived: sum of 2 quarters · filed 2017-03-15 | $348.66K derived: sum of 3 quarters · filed 2017-03-15 | $417.66K derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $113.21K 10-K · filed 2016-03-14 | $210.39K derived: sum of 2 quarters · filed 2016-03-14 | $279.38K derived: sum of 3 quarters · filed 2016-03-14 | $331.46K 10-K · filed 2017-03-15 |
| 2014-09-30 | $97.17K 10-K · filed 2016-03-14 | $166.17K derived: sum of 2 quarters · filed 2016-03-14 | $218.25K 10-Q · filed 2015-11-09 | $226.82K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $69.00K 10-K · filed 2016-03-14 | $121.08K 10-Q · filed 2015-08-10 | $129.65K derived: sum of 3 quarters · filed 2016-03-14 | $176.44K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $52.08K 10-K · filed 2016-03-14 | $60.65K derived: sum of 2 quarters · filed 2016-03-14 | $107.44K derived: sum of 3 quarters · filed 2016-03-14 | $144.83K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $8.58K 10-K · filed 2015-03-16 | $55.36K derived: sum of 2 quarters · filed 2015-03-16 | $92.75K derived: sum of 3 quarters · filed 2015-03-16 | $132.21K 10-K · filed 2016-03-14 |
| 2013-09-30 | $46.79K 10-K · filed 2015-03-16 | $84.18K derived: sum of 2 quarters · filed 2015-03-16 | $123.64K 10-Q · filed 2014-11-10 | $180.16K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $37.39K 10-K · filed 2015-03-16 | $76.85K 10-Q · filed 2014-08-11 | $133.37K derived: sum of 3 quarters · filed 2015-03-16 | $170.38K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $39.46K 10-K · filed 2015-03-16 | $95.98K derived: sum of 2 quarters · filed 2015-03-16 | $132.99K derived: sum of 3 quarters · filed 2015-03-16 | $174.03K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $56.52K 10-K · filed 2014-03-17 | $93.53K derived: sum of 2 quarters · filed 2014-03-17 | $134.57K derived: sum of 3 quarters · filed 2014-03-17 | $166.11K 10-K · filed 2015-03-16 |
| 2012-09-30 | $37.01K 10-K · filed 2014-03-17 | $78.05K derived: sum of 2 quarters · filed 2014-03-17 | $109.59K 10-Q · filed 2013-11-12 | $128.49K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $41.04K 10-K · filed 2014-03-17 | $72.58K 10-Q · filed 2013-08-09 | $91.47K derived: sum of 3 quarters · filed 2014-03-17 | $97.21K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $31.54K 10-K · filed 2014-03-17 | $50.44K derived: sum of 2 quarters · filed 2014-03-17 | $56.17K derived: sum of 3 quarters · filed 2014-03-17 | $63.97K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $18.89K 10-K · filed 2013-03-18 | $24.63K derived: sum of 2 quarters · filed 2013-03-18 | $32.43K derived: sum of 3 quarters · filed 2013-03-18 | $34.28K 10-K · filed 2014-03-17 |
| 2011-09-30 | $5.74K 10-K · filed 2013-03-18 | $13.54K derived: sum of 2 quarters · filed 2013-03-18 | $15.39K 10-Q · filed 2012-11-07 | |
| 2011-06-30 | $7.80K 10-K · filed 2013-03-18 | $9.65K 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $1.85K 10-K · filed 2013-03-18 | |||
| 2010-12-31 | $147.41K 10-K · filed 2013-03-18 | |||
| 2009-12-31 | $30.33K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |